KaydedilenlerDerginizi ekleyin

Dergiler / The Anatolian Journal of Cardiology / 2017 / Cilt: 17 - Sayı: 5

Baseline serum globulin as a predictor of the recurrence of lone atrial fibrillation after radiofrequency catheter ablation

Qing ZHOU
Hailong CAO
Zhenjun XU
Rongfang LAN
Xin CHEN
Dongjin WANG
Wei XU
Sayfa
381–385
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, it may be used as a predictor of AF recurrence in these patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Inflammation and autoimmune responses play an important role in recurrence of atrial fibrillation (AF).
📊
Temel Bulgular & Veri:This study aimed to determine the relationship between baseline serum globulin levels and the risk of recurrence after ablation in lone AF patients.Methods: We enrolled 348 lone AF patients undergoing radiofrequency catheter ablation for the first time for whom complete follow-up data were available.
💡
Sonuç & Katkı:Therefore, it may be used as a predictor of AF recurrence in these patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Inflammation and autoimmune responses play an important role in recurrence of atrial fibrillation (AF). Serum globulin levels are a commonly used clinical index that represents inflammation and autoimmune response. This study aimed to determine the relationship between baseline serum globulin levels and the risk of recurrence after ablation in lone AF patients.Methods: We enrolled 348 lone AF patients undergoing radiofrequency catheter ablation for the first time for whom complete follow-up data were available. Pre-ablation peripheral venous blood samples were obtained for measurement of serum globulin levels.Results: During the follow-up period of 22 months (range, 6-62), AF recurred in 129 patients (37.1%). Recurrence was associated with a low level of pre-ablation serum globulins. Multiple Cox proportional hazard regression analysis showed that persistent AF, AF duration, left atrial diameter, no amiodarone after ablation, and the serum globulin level in particular were independent predictors of AF recurrence. According to receiver operating characteristic curve analysis, the best diagnostic cut-off serum globulin level was 25.4 g/L, which showed 74.4% sensitivity, 71.3% specificity, and 73.3% accuracy.Conclusion: The baseline low serum globulin level is associated with AF recurrence after first-time ablation in lone AF patients. Therefore, it may be used as a predictor of AF recurrence in these patients.

🔖

Bu Makaleye Atıf Yap

ZHOU, Q., CAO, H., XU, Z., LAN, R., CHEN, X., WANG, D., XU, W. (2017). Baseline serum globulin as a predictor of the recurrence of lone atrial fibrillation after radiofrequency catheter ablation. The Anatolian Journal of Cardiology, Cilt: 17 - Sayı: 5, 381–385. https://ajindex.com/articles/365350

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6: 213-20.
  2. Boersma LV, Castella M, van Boven W, Berruezo A, Yılmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation 2012; 125: 23-30.
  3. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol 2014; 63: 2335-45.
  4. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007; 50: 2021-8.
  5. Lee HC, Huang KT, Wang XL, Shen WK. Autoantibodies and cardiac arrhythmias. Heart Rhythm 2011; 8: 1788-95.
  6. Lim HS, Schultz C, Dang J, Alasady M, Lau DH, Brooks AG, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrilla- tion. Circ Arrhythm Electrophysiol 2014; 7: 83-9.
  7. Lazzerini PE, Capecchi PL, Guideri F, Acampa M, Selvi E, Bisogno S, et al. Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol 2008; 103: 1-11.
  8. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiolo- gy Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 123: e269-367. Cao H, Wu Y, Li Q, Wu Y, Zhou Q, Rİe OD, et al. Serum sRANKL/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation. Int J Cardiol 2014; 170: 298-302.
  9. Hakalahti A, Biancari F, Nielsen JC, Raatikainen MJ. Radiofrequen- cy ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analy- sis. Europace 2015; 17: 370-8.
  10. Allessie M, Ausma J, Schotten U. Electrical, contractile and struc- tural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-46.
  11. Cao H, Li Q, Li M, Od R, Wu Z, Zhou Q, et al. Osteoprotegerin/RANK/ RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. Int J Cardiol 2013; 166: 702-8.
  12. Xi L, Cao H, Zhu J, Rİe OD, Li M, Wu Y, et al. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm